Piezo1 activation protects against sepsis-induced myocardial dysfunction in a pilot study

Angwei Gong1, Jing Dai2, Yan Zhao1

  • 1Department of Cardiology, The Second Hospital of Hebei Medical University, Hebei, 050000, China.

Scientific Reports
|May 9, 2025
PubMed

Insights

Piezo1 channels protect the heart during sepsis. Activating Piezo1 improved cardiac function in sepsis-induced myocardial dysfunction, while blocking it worsened the condition, suggesting a therapeutic target.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Sepsis-induced myocardial dysfunction (SIMD) is a critical complication of sepsis.
  • The role of mechanosensitive ion channels, like Piezo1, in SIMD remains unclear.

Purpose of the Study:

  • To investigate the function of Piezo1 in SIMD.
  • To elucidate the underlying molecular mechanisms involving Dual Specificity Phosphatase 3 (DUSP3).

Main Methods:

  • Established a SIMD mouse model using lipopolysaccharide (LPS).
  • Utilized Piezo1 agonist (Yoda1), inhibitor (GsMTx-4), and cardiomyocyte-specific Piezo1 knockout (Piezo1ΔCM) mice.
  • Assessed cardiac function, histology, Piezo1, cardiac troponin T (cTnT), and DUSP3 protein levels.

Main Results:

  • SIMD mice showed impaired cardiac function, elevated Piezo1, and cTnT.
  • Piezo1 activation improved cardiac function and reduced injury; inhibition exacerbated SIMD.
  • Piezo1ΔCM mice exhibited worsened cardiac dysfunction and injury, with elevated DUSP3.

Conclusions:

  • Piezo1 plays a protective role in sepsis-induced myocardial dysfunction.
  • Piezo1 may exert its protective effects by modulating DUSP3 levels.
  • Targeting Piezo1 could be a potential therapeutic strategy for SIMD.

Related Concept Videos